Statin use and the risk of Parkinson disease: a nested case control study

2008 ◽  
Vol 15 (11) ◽  
pp. 1272-1273 ◽  
Author(s):  
Ali Samii ◽  
Bruce C. Carleton ◽  
Mahyar Etminan
Keyword(s):  
Parkinson Disease ◽  
Case Control Study ◽  
Case Control ◽  
Nested Case Control ◽  
Control Study ◽  
Statin Use

Statin Use Reduces Risk of Esophageal Adenocarcinoma in US Veterans With Barrett’s Esophagus: A Nested Case-Control Study

2015 ◽  
Vol 149 (6) ◽  
pp. 1392-1398 ◽  
Author(s):  
Theresa Nguyen ◽  
Zhigang Duan ◽  
Aanand D. Naik ◽  
Jennifer R. Kramer ◽  
Hashem B. El-Serag
Keyword(s):  
Barrett’S Esophagus ◽  
Esophageal Adenocarcinoma ◽  
Barrett's Esophagus ◽  
Case Control Study ◽  
Case Control ◽  
Us Veterans ◽  
Nested Case Control ◽  
Control Study ◽  
Statin Use

Statin use and risk of cataract: A nested case-control study within a healthcare database

2016 ◽  
Vol 251 ◽  
pp. 153-158 ◽  
Author(s):  
Manuela Casula ◽  
Davide Soranna ◽  
Giovanni Corrao ◽  
Luca Merlino ◽  
Alberico Luigi Catapano ◽  
...  
Keyword(s):  
Case Control Study ◽  
Case Control ◽  
Healthcare Database ◽  
Nested Case Control ◽  
Control Study ◽  
Statin Use

scholarly journals Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study

2016 ◽  
Vol 215 (6) ◽  
pp. 750.e1-750.e8 ◽  
Author(s):  
Mostafa A. Borahay ◽  
Xiao Fang ◽  
Jacques G. Baillargeon ◽  
Gokhan S. Kilic ◽  
Darren F. Boehning ◽  
...  
Keyword(s):  
Uterine Fibroid ◽  
Case Control Study ◽  
Case Control ◽  
Nested Case Control ◽  
Control Study ◽  
Statin Use

Sa1958 Statin Use May Decrease the Risk of Esophageal Adenocarcinoma (EA): A Nested Case-Control Study of US Veterans

2015 ◽  
Vol 148 (4) ◽  
pp. S-367
Author(s):  
Theresa Nguyen ◽  
Zhigang Duan ◽  
Aanand Naik ◽  
Jennifer R. Kramer ◽  
Hashem B. El-Serag
Keyword(s):  
Esophageal Adenocarcinoma ◽  
Case Control Study ◽  
Case Control ◽  
Us Veterans ◽  
Nested Case Control ◽  
Control Study ◽  
Statin Use

scholarly journals Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study

2014 ◽  
Vol 12 (8) ◽  
pp. 1207-1215 ◽  
Author(s):  
M. Schmidt ◽  
S. C. Cannegieter ◽  
S. A. Johannesdottir ◽  
O. M. Dekkers ◽  
E. Horváth-Puhó ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Case Control Study ◽  
Case Control ◽  
Venous Thromboembolism Recurrence ◽  
Nested Case Control ◽  
Control Study ◽  
Statin Use

scholarly journals Statin Use and Chronic Lymphocytic Leukemia Incidence: A Nested Case–Control Study in Manitoba, Canada

2019 ◽  
Vol 28 (9) ◽  
pp. 1495-1501 ◽  
Author(s):  
Christiaan H. Righolt ◽  
Geng Zhang ◽  
Xibiao Ye ◽  
Versha Banerji ◽  
James B. Johnston ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Case Control Study ◽  
Case Control ◽  
Lymphocytic Leukemia ◽  
Nested Case Control ◽  
Control Study ◽  
Statin Use

Association Between Sudden Sensorineural Hearing Loss and History of Statin Use: A Nested Case-Control Study

2020 ◽  
pp. 019459982096963
Author(s):  
So Young Kim ◽  
Jee Hye Wee ◽  
Chanyang Min ◽  
Dae Myoung Yoo ◽  
Hyo Geun Choi
Keyword(s):  
Hearing Loss ◽  
Case Control Study ◽  
Case Control ◽  
Sudden Sensorineural Hearing Loss ◽  
Subgroup Analyses ◽  
Region Of Residence ◽  
History Of ◽  
Nested Case Control ◽  
Control Study ◽  
Statin Use

Objective The effect of statin on sudden sensorineural hearing loss (SSNHL) remains unclear. Thus, this study aimed to investigate the association between prior statin use and SSNHL. Study Design A nested case-control study. Setting Participants aged ≥40 years were enrolled from the 2002-2015 Korean National Health Insurance Service–Health Screening Cohort. Methods A total of 5876 patients with SSNHL were matched with 23,504 control participants for age, sex, income, and region of residence. History of statin use for 2 years before SSNHL onset was investigated between the groups. The odds ratios (ORs) of the length of statin use for SSNHL stratified by age, sex, income, and region of residence were analyzed with conditional logistic regression. Dyslipidemia, total cholesterol, blood pressure, blood glucose, hemoglobin, obesity, smoking, alcohol consumption, and Charlson Comorbidity Index score were adjusted. The adjusted variables were subjected to subgroup analyses. Results The SSNHL group had a longer duration of statin use than the control group (mean [SD], 81.9 [197.7] days vs 72.7 [188.0] days; P = .001). However, statin use was not associated with SSNHL after adjusting for the confounders (adjusted OR, 1.04; 95% CI, 0.98-1.11; P = .245). There was a positive correlation between statin use and SSNHL in the crude model (crude OR, 1.10; 95% CI, 1.04-1.16; P = .001). However, there was no association between statin use and SSNHL in all subgroup analyses. Conclusion Previous statin use was not associated with SSNHL.

Sign in / Sign up

Export Citation Format

Share Document